Patient medication - thalidomide 100MG - ship to baltimore VA medical center pharmacy.
Ended Awarded
- Contract number
- 36C24526N0552
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $5,814
Award facts
- Contract value 100% obligated
- $5,814.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Memphis, TN 38141, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company has been awarded a delivery order valued at $5,814.24 under its Federal Supply Schedule contract (GSA Schedule 36F79724D0101) with the Department of Veterans Affairs for the supply of Thalidomide 100mg pharmaceutical products. This firm fixed-price delivery order, issued under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule, will be performed at Bristol-Myers Squibb's facility in Memphis, Tennessee, with delivery to the Baltimore VA Medical Center Pharmacy. The award was issued on April 28, 2026, with an ultimate completion date of May 1, 2026, and represents a BPA call under the larger GSA Schedule vehicle. No set-aside designation has been applied to this contract award.
This delivery order supports the Veterans Integrated Service Network 5's mission to provide pharmaceutical therapies to eligible veterans through the Department of Veterans Affairs healthcare system. Bristol-Myers Squibb's Federal Supply Schedule contract, which carries a substantial ceiling value of $12.3 billion and extends through April 30, 2029, serves as the primary vehicle through which the VA procures advanced pharmaceutical products, including specialty oncology and immunotherapy treatments. The company has maintained an active federal contractor relationship since 2006 and has received more than fifty documented delivery orders from the VA since 2022, demonstrating sustained demand for its specialized pharmaceutical products across multiple Veterans Integrated Service Networks.
Quick answers
Who was awarded contract 36C24526N0552?
36C24526N0552 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 28, 2026.
How much is contract 36C24526N0552 worth?
The government has obligated $5,814 on 36C24526N0552.
Is contract 36C24526N0552 an order under another contract?
Yes. 36C24526N0552 is a BPA call under 36F79724D0101-36E79726A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0552 competed?
The extent of competition for 36C24526N0552 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award